Aging Global Population Will Boost Ocular Treatment Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
14 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$6.00
93.2% undervalued intrinsic discount21 Aug
US$0.41
1Y
-60.1%7D
-3.7%